Bayer says Xarelto isn't losing U.S. market share to Eliquis
April 30, 2015 at 09:15 AM EDT
FRANKFURT, April 30 (Reuters) - Bayer brushed off concern that its stroke prevention pill Xarelto may be losing market share to rival Bristol-Myers Squibb's Eliquis in the United States.
